CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Cancer Network
Original article

<![CDATA[How Can Cooperative Groups Close Outcome Gaps in HIV-Associated Lymphoma?]]>

Neutral
AI Analysis

Summary

Dr. Paul G. Rubinstein advocates for inclusive clinical trial practices, emphasizing that patients with HIV-associated cancers should not be excluded from cooperative group studies.

Importance:2/10
Sentiment:
0.00
HIV-associated lymphomaclinical trialscooperative groupspatient inclusion

Read the original article

Published by Cancer Network on October 8, 2026 6:00 PM

Read Original